Digital Pathology Platforms : Digital Pathology Platform

Tribun Health’s recent FDA 510(k) clearance for its CaloPix® digital pathology platform marks a significant advancement in vendor-agnostic pathology solutions. The innovation is now validated for compatibility with two major whole slide scanners, including the Hamamatsu NanoZoomer S360MD and the Leica Aperio GT450 DX.

The regulatory milestone strengthens the digital pathology platform’s position as an enterprise-ready system. The distinction builds on CaloPix®’s existing CE marking and Health Canada approval, alongside its proven adoption across 100+ European and Canadian healthcare institutions.

The platform’s web-based, zero-footprint architecture eliminates local installation barriers, enabling seamless deployment across multi-site health networks. Its cloud-ready design future-proofs institutions for scalable digital pathology adoption, while features like high-throughput case management, LIS/VNA integration, and built-in telepathology tools directly address operational pain points by reducing diagnostic turnaround times and facilitating remote collaborations.

Image Credit: Tribun Health